Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19

1 May 2023

Abstract excerpt

INTRODUCTION: Covid-19 is linked with the development of cardio-metabolic disorders, including dyslipidemia, dysregulation of high-density lipoprotein (HDL), and low-density lipoprotein (LDL). Furthermore, SARS-Co-2 infection is associated with noteworthy changes in lipid profile, which is suggested as a possible biomarker to support the diagnosis and management of Covid-19. METHODS: This paper adopts the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Diverse Scientific Research Studies
Share to Long-Term Effects of COVID-19

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37249296
DOI: 10.1002/iid3.861

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19PMID 37249296Read ↗

The role of cholesterol metabolism in predicting clinical outcome of patients with severe COVID-19Semantic proximity Read ↗

Lp-Pla2 As A Biomarker and Its Possible Associations with Sars-Cov-2 InfectionSemantic proximity Read ↗

Altered Lipid Profile in COVID-19 Patients and Metabolic ReprogrammingSemantic proximity Read ↗

An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read ↗

<strong></strong>An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read ↗

Aterosclerosis, Cardiovascular Disorders And Covid-19: Comorbid PathogenesisSemantic proximity Read ↗

The relationship between microRNAs and COVID-19 complicationsSemantic proximity Read ↗

The COVID-19 pandemic: a global health crisis.Semantic proximity Read ↗

Unraveling the molecular crosstalk between Atherosclerosis and COVID-19 comorbiditySemantic proximity Read ↗

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbiditySemantic proximity Read ↗

Molecular Aspects of COVID-19 Differential PathogenesisSemantic proximity Read ↗

Advances in Understanding Long COVID: Pathophysiological Mechanisms and the Role of Omics Technologies in Biomarker IdentificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.